Compounds > gabapentin-lactam
Page last updated: 2024-08-23

gabapentin-lactam and Disease Models, Animal

gabapentin-lactam has been researched along with Disease Models, Animal in 3 studies

*Disease Models, Animal: Naturally-occurring or experimentally-induced animal diseases with pathological processes analogous to human diseases. [MeSH]

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (66.67)29.6817
2010's1 (33.33)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Alamry, KA; Goncalves, K; Ibrahim, MA; Katritzky, AR; Lebedyeva, IO; Neubert, J; Ostrov, DA; Patel, K; Sileno, SM; Steel, PJ1
Feuerstein, TJ; Gerds, TA; Landwehrmeyer, GB; Lücking, CH; Ludin, DE; Zucker, B1
Feuerstein, TJ; Jehle, T; Lagrèze, WA1

Other Studies

3 other study(ies) available for gabapentin-lactam and Disease Models, Animal

ArticleYear
Gabapentin hybrid peptides and bioconjugates.
    Bioorganic & medicinal chemistry, 2014, Feb-15, Volume: 22, Issue:4

    Topics: Acylation; Amines; Analgesics; Animals; Behavior, Animal; Crystallography, X-Ray; Cyclization; Cyclohexanecarboxylic Acids; Disease Models, Animal; Gabapentin; gamma-Aminobutyric Acid; Mice; Molecular Conformation; Pain; Peptides

2014
Gabapentin-lactam, but not gabapentin, reduces protein aggregates and improves motor performance in a transgenic mouse model of Huntington's disease.
    Naunyn-Schmiedeberg's archives of pharmacology, 2004, Volume: 370, Issue:2

    Topics: Amines; Animals; Anticonvulsants; Aza Compounds; Corpus Striatum; Cyclohexanecarboxylic Acids; Disease Models, Animal; Female; Gabapentin; gamma-Aminobutyric Acid; Hippocampus; Huntington Disease; Injections, Subcutaneous; Male; Mice; Mice, Transgenic; Motor Activity; Neuroprotective Agents; Spiro Compounds; Survival Rate

2004
[The effect of gabapentin and gabapentin-lactam on retinal ganglion cell survival. Situation after acute retinal ischemia in animal models].
    Der Ophthalmologe : Zeitschrift der Deutschen Ophthalmologischen Gesellschaft, 2001, Volume: 98, Issue:3

    Topics: Acetates; Amines; Animals; Anticonvulsants; Aza Compounds; Cell Survival; Convulsants; Cyclohexanecarboxylic Acids; Disease Models, Animal; Gabapentin; gamma-Aminobutyric Acid; Glutamates; In Vitro Techniques; Ischemia; Male; Neuroprotective Agents; Rats; Rats, Sprague-Dawley; Receptors, Glutamate; Retinal Diseases; Retinal Ganglion Cells; Retinal Vessels; Spiro Compounds; Time Factors

2001